Somalogic stock.

SomaLogic is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado. It became listed on Nasdaq in September 2021 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. [2] Mar 15, 2023 · And there's no doubt that SomaLogic, Inc. (NASDAQ:SLGC) stock has had a really bad year. In that relatively short period, the share price has plunged 69%. Because SomaLogic hasn't been listed for ... SomaLogic, Inc. (NASDAQ:SLGCW – Get Free Report)’s stock price rose 6.3% on Wednesday . The company traded as high as $0.17 and last traded at $0.17. Approximately 72,147 shares were traded during trading, an increase of 1,225% from the average daily volume of 5,446 shares. The stock had previously closed at $0.16. SomaLogic Stock PerformanceAppointed Eliot Lurier, CPA, to Interim Chief Financial Officer. Second Quarter 2023 Financial Results. Revenue for the three months ended June 30, 2023 was $20.5 million, a 45% increase from $14.1 million in the corresponding period of 2022. Excluding Q2 2022 royalty revenue from NEB, revenue grew 55%. Gross margin for the …

Nov 18, 2022 · With the stock on the backfoot, Wood evidently thinks it offers good value. Ark Invest opened a new position in SomaLogic in Q3 and snapped up 11,017,672 shares. These are currently worth over $29 ... SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools …BOULDER, Colo., March 13, 2023 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in proteomics technology, recently completed the 7,000-plex assay on and delivered data for 4,000 plasma samples from the China Kadoorie Biobank (CKB), one of the world’s largest prospective studies.

Mar 28, 2023 · SomaLogic projects revenue for the full year 2023 to range from $80 million to $84 million. Webcast and Conference Call Details. SomaLogic will host a conference call at 4:30 p.m. ET on Tuesday, March 28, 2023 to discuss its fourth quarter 2022 financial results. Those interested in listening to the conference call should register online here ... Nov 9, 2023 · BOULDER — Biotechnology company SomaLogic Inc. (Nasdaq: SLGC) nearly halved its year-over-year third quarter sales, but still managed to beat Wall Street expectations as it prepares for a $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB). SomaLogic develops platforms to read thousands of proteins in a patient’s ...

Track SomaLogic Inc - Ordinary Shares - Class A (SLGC) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSomalogic stock was originally listed at a price of $12.49 in Feb 23, 2021. If you had invested in Somalogic stock at $12.49, your return over the last 2 years would have been -81.91%, for an annualized return of -57.46% (not including any dividends or dividend reinvestments).Aug 15, 2023 · Shares of SomaLogic (SLGC-0.35%) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock ... Standard BioTools ( NASDAQ: LAB) said it will combine in an all stock merger with SomaLogic ( NASDAQ: SLGC) The combined company will have a pro forma equity value of over $1B as per LAB's closing ...Jefferies Downgrades SomaLogic to Hold From Buy, Adjusts Price Target to $2.30 From $3.50. Oct. 05. MT. Canaccord Genuity Downgrades SomaLogic to Hold From Buy, Cuts Price Target to $2.50 From $5. Sep. 25. MT. Canaccord Genuity Adjusts Price Target on SomaLogic to $5 From $6, Maintains Buy Rating. Mar. 29.

SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold …

Oct 4, 2023 · SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools shareholders will own 43% of the ...

Standard BioTools Inc. and SomaLogic Inc. have agreed to merge in an all-stock deal to combine suppliers of tools to the medical research and drug development industry. The deal gives the combined ...of SomaLogic Operating Co., Inc. and any third-party trademarks used herein are the property of their respective owners. For Research Use Only (RUO). Not intended for diagnostic or patient management purposes. Somalogic Co. Inc. is certified to ISO 9001:2015, accredited to ISO 27001:2013 and ISO 15189:2012, and is a CAP-accredited CLIA laboratory.Public companies currently own 5.5% of SomaLogic stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged.SLGC Sales Forecast. Next quarter’s sales forecast for SLGC is $21.05M with a range of $20.60M to $21.60M. The previous quarter’s sales results were $22.05M. SLGC beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 45.92% of the time in the same period.Information concerning SomaLogic’s directors and executive officers, including their ownership of SomaLogic securities, is set forth in the joint proxy …

View Your Watchlist. Stock analysis for SomaLogic Inc (SLGC:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and …SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold …Stock analysis for SomaLogic Inc (CMIIU:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Under the terms of the agreement, which was unanimously approved by the participating members of the boards of directors of both companies, SomaLogic …Mar 28, 2023 · SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate ... (c) such stockholder’s earn-out pro rata share of any Earn-Out Shares (as defined below) to which such stockholder is entitled pursuant to the terms of the Merger Agreement.. The exchange ratio is currently expected to be 0.8426 shares of CMLS II Class A common stock per share of SomaLogic’s Class B common stock, after giving effect …Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …

Private companies and public companies own 3.6% and 5.5% of SomaLogic stock respectively. Understanding the ownership structure of a company is crucial in assessing its potential future performance. However, it is important to consider various other factors when making investment decisions. Conducting thorough research and analysis, …

SAN DIEGO, Jan. 5, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced it has entered into a definitive co-development agreement with SomaLogic to bring the SomaScan® Proteomics Assay onto Illumina's current and future high throughput next-generation sequencing (NGS) platforms. This partnership accelerates the rapidly …The average price point forecasted by analysts for SomaLogic Inc (SLGC) is $4.70, which is $2.18 above the current market price. The public float for SLGC is 152.97M, and currently, short sellers hold a 5.10% ratio of that floaft. The average trading volume of SLGC on November 15, 2023 was 1.50M shares. Top 5 AI Stocks to Buy for [email protected] look at Olink stock. 4.2 billion market cap. it may actually be the largest proteomic stock. they use aptamers like somalogic. Reply Like. h. highgrowthinvestment. 08 Aug. 2021.BOULDER — Biotechnology company SomaLogic Inc. (Nasdaq: SLGC) nearly halved its year-over-year third quarter sales, but still managed to beat Wall Street expectations as it prepares for a $1 billion merger with California-based Standard BioTools Inc. (Nasdaq: LAB). SomaLogic develops platforms to read thousands of proteins in a patient’s ...Stock analysis for SomaLogic Inc (CMIIU:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Explore new charts. Discover historical prices for SLGC stock on Yahoo Finance. View daily, weekly or monthly format back to when SomaLogic, Inc. stock was issued.

Stock analysis for SomaLogic Inc (CMIIU:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

Somalogic Inc stock performance at a glance. Check Somalogic Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. SLGC Stock Performance. USD USD; Previous close: 2.71: 2.71: Day range: 2.72 - 2.862.72 - 2.86Year range: 1 - 31 - 3Market cap: 517198000: 517198000:

Sep 25, 2023 · The current consensus among the four polled investment analysts is to buy stock in Somalogic Inc. This rating has remained steady since January, indicating a consistent positive outlook for the company’s performance. Somalogic Inc reported earnings per share of -$0.13 for the current quarter, suggesting a loss during this period. The stock is currently trading at $2.47 and its $5.06 average price target implies ~105% upside potential by the end of this year. (See BFLY stock forecast ) SomaLogic, Inc. ( SLGC )THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between SomaLogic, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the SomaLogic, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time …About the SLGC stock forecast. As of 2023 November 13, Monday current price of SLGC stock is 2.480$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Somalogic stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given …9 oct 2023 ... Mintz is proud to represent Standard BioTools Inc. in its all-stock merger deal with SomaLogic. Our deal team was led by Matthew Gardella, ...Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, …The average Somalogic stock price prediction forecasts a potential downside of 2.04% from the current SLGC share price of $2.45. What is SLGC's forecast return on assets (ROA) for 2023-2025? (NASDAQ: SLGC) forecast ROA is -9.99%, which is lower than the forecast US Health Information Services industry average of 8.41%.Nov 18, 2022 · With the stock on the backfoot, Wood evidently thinks it offers good value. Ark Invest opened a new position in SomaLogic in Q3 and snapped up 11,017,672 shares. These are currently worth over $29 ... Information concerning SomaLogic’s directors and executive officers, including their ownership of SomaLogic securities, is set forth in the joint proxy …SomaLogic: A Look into Hedge Fund Activity and Stock Ratings SomaLogic Inc. (NASDAQ:SLGC) has recently caught the attention of large investors, as Mitchell Mcleod Pugh & Williams Inc. and Raymond James & Associates both bought new positions in the company worth $30,000 and $33,000 respectively.

Sep 25, 2023 · The current consensus among the four polled investment analysts is to buy stock in Somalogic Inc. This rating has remained steady since January, indicating a consistent positive outlook for the company’s performance. Somalogic Inc reported earnings per share of -$0.13 for the current quarter, suggesting a loss during this period. After this action, Taich Adam now owns 238,643 shares of SomaLogic Inc, valued at $50,286 using the latest closing price. Gutierrez Ruben, the General Counsel of SomaLogic Inc, sale 9,211 shares at $2.33 during a trade that took place back on Sep 15, which means that Gutierrez Ruben is holding 110,534 shares at $21,460 based on the most recent ...Real time SomaLogic (SLGC) stock price quote, stock graph, news & analysis.Instagram:https://instagram. top 5g companies to invest inbest dental insurance for self employedwhy tesla stock is down todaystocks trading simulator Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ... 1976 bicentenial quartermbly stock SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized ...Get the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend yield, market cap, beta, PE ratio, EPS and more. best broker for penny stock trading Public companies currently own 5.5% of SomaLogic stock. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged.--SomaLogic, Inc., a leader in proteomics technology, today reported financial results for the quarter ended March 31, 2023. ... Common stock, $0.0001 par value; ...Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health – today reported financial results for the third quarter …